HDFC Mutual Fund Acquires 10 Lakh Global Health Shares for ₹130 Crore
HDFC Mutual Fund has significantly increased its footprint in the healthcare sector by acquiring an additional 10 lakh shares of Global Health, the operator of the renowned Medanta hospital chain. This strategic move through open market transactions underscores growing institutional confidence in the company's long-term growth trajectory.
Strategic Stake Acquisition via Block Deal
In a significant market transaction recorded on the BSE, HDFC Mutual Fund purchased 10 lakh shares of Global Health at an average price of ₹1,300 per share. This latest acquisition, valued at approximately ₹130 crore, represents a 0.37 per cent stake in the company. The shares were offloaded by Sunil Sachdeva, a co-founder of Medanta Hospitals.
This is not an isolated investment; it follows a similar pattern of accumulation by the fund house. Just last month, HDFC Mutual Fund had already purchased 10 lakh shares from Sachdeva for a consideration of over ₹122 crore. As of the end of the March quarter, Sachdeva held 2.90 crore equity shares, representing a 10.79 per cent stake in the healthcare major.
Robust Financial Performance Driving Investor Interest
The aggressive accumulation by institutional players like HDFC Mutual Fund comes on the heels of impressive quarterly financial results from Global Health. The company has demonstrated strong momentum in both its top-line and bottom-line figures, reinforcing its position in the competitive Indian healthcare market.
For the fourth quarter ended March 31, 2026, Global Health reported a substantial 39.7 per cent increase in Profit After Tax (PAT), reaching ₹141.7 crore. This is a significant jump from the ₹101.4 crore PAT reported in the corresponding quarter of the previous fiscal year.
Furthermore, the company's revenue from operations showed healthy growth, climbing to ₹1,159 crore in the latest quarter compared to ₹931.3 crore in the year-ago period. This robust operational efficiency and revenue scaling continue to make the Medanta-led chain an attractive prospect for large-scale institutional investors.
Market Reaction and Valuation
Despite the significant news of the block deal, the stock market showed a slight correction in the immediate aftermath. Shares of Global Health slipped 0.41 per cent on the BSE, closing at ₹1,311.35 per share.
The entry of HDFC Mutual Fund at a price of ₹1,300 per share provides a clear valuation benchmark for the market. For business professionals and investors, this transaction highlights a clear trend: large mutual funds are looking to capitalize on the expanding healthcare infrastructure in India, specifically targeting established players with proven profitability and scaling capabilities.
Key Takeaways
- Increased Exposure: HDFC Mutual Fund has expanded its stake in Global Health by 0.37% through a ₹130 crore transaction involving 10 lakh shares.
- Strong Profitability: Global Health reported a nearly 40% surge in PAT to ₹141.7 crore for the final quarter of FY26, driven by rising operational revenues.
- Institutional Confidence: This follow-up purchase, occurring just a month after a similar ₹122 crore deal, signals high conviction from major fund managers regarding the Medanta brand's growth.